Abstract
Successful management of a heavily pretreated 58-year-old woman with metastatic esthesioneuoblastoma using temozolomide is reported. There is no standard treatment of this tumors with extra- and intracranial manifestations. The response, long term stability and high quality of life using temozolomide for this tumor entity should be recognized.
Similar content being viewed by others
References
Finkelstein SD, Hirose T, VandenBerg SR: Olfactory neuroblastoma. In: Kleihues P, Cavenee WK (eds). World Health Organization Classification of Tumors of the Nervous System. IARC Press, Lyon, 2000, pp 150-152
Levine PA, Gallagher R, Cantrell RW: Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 109: 1539-1543, 1999
Chamberlain MC: Treatment of intracranial meta-static esthesioneuroblastoma. Cancer 95: 243-248, 2002
Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83: 588-593, 2000
Chamberlain MC: Treatment of intracranial meta-static esthesioneuroblastoma. J Clin Oncol 20: 357-358, 2002
Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M: A prospective study on glioblastoma in the elderly. Cancer 97: 657-662, 2003
McElroy EA Jr, Buckner J, Lewis JE: Chemotherapy for advanced esthesioneurobalstoma: The Mayo Clinic experience. Neurosurgery 42: 1023-1027, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wick, W., Wick, A., Küker, W. et al. Intracranial Metastatic Esthesioneuroblastoma Responsive to Temozolomide. J Neurooncol 70, 73–75 (2004). https://doi.org/10.1023/B:NEON.0000040826.30636.4a
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000040826.30636.4a